AERSALE CORP (ASLE) Fundamental Analysis & Valuation

NASDAQ:ASLE • US00810F1066

Current stock price

6.16 USD
-0.12 (-1.91%)
At close:
6.16 USD
0 (0%)
After Hours:

This ASLE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ASLE Profitability Analysis

1.1 Basic Checks

  • In the past year ASLE was profitable.
  • In the past year ASLE had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ASLE reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: ASLE reported negative operating cash flow in multiple years.
ASLE Yearly Net Income VS EBIT VS OCF VS FCFASLE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

  • ASLE's Return On Assets of 0.91% is in line compared to the rest of the industry. ASLE outperforms 46.15% of its industry peers.
  • The Return On Equity of ASLE (1.41%) is comparable to the rest of the industry.
  • ASLE has a Return On Invested Capital (1.78%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.91%
ROE 1.41%
ROIC 1.78%
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ASLE Yearly ROA, ROE, ROICASLE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

  • ASLE's Profit Margin of 1.73% is in line compared to the rest of the industry. ASLE outperforms 46.15% of its industry peers.
  • In the last couple of years the Profit Margin of ASLE has declined.
  • ASLE has a Operating Margin of 4.03%. This is comparable to the rest of the industry: ASLE outperforms 42.31% of its industry peers.
  • ASLE's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 30.83%, ASLE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • ASLE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.03%
PM (TTM) 1.73%
GM 30.83%
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
ASLE Yearly Profit, Operating, Gross MarginsASLE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. ASLE Health Analysis

2.1 Basic Checks

  • ASLE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ASLE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ASLE Yearly Shares OutstandingASLE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ASLE Yearly Total Debt VS Total AssetsASLE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.14 indicates that ASLE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ASLE has a worse Altman-Z score (2.14) than 69.23% of its industry peers.
  • A Debt/Equity ratio of 0.30 indicates that ASLE is not too dependend on debt financing.
  • ASLE's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. ASLE outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.14
ROIC/WACC0.17
WACC10.48%
ASLE Yearly LT Debt VS Equity VS FCFASLE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

  • ASLE has a Current Ratio of 4.41. This indicates that ASLE is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of ASLE (4.41) is better than 79.49% of its industry peers.
  • ASLE has a Quick Ratio of 4.41. This is a bad value and indicates that ASLE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ASLE has a Quick ratio of 0.92. This is in the lower half of the industry: ASLE underperforms 76.92% of its industry peers.
Industry RankSector Rank
Current Ratio 4.41
Quick Ratio 0.92
ASLE Yearly Current Assets VS Current LiabilitesASLE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. ASLE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.21% over the past year.
  • Measured over the past years, ASLE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -33.12% on average per year.
EPS 1Y (TTM)84.21%
EPS 3Y-33.12%
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.02%

3.2 Future

  • Based on estimates for the next years, ASLE will show a very strong growth in Earnings Per Share. The EPS will grow by 65.07% on average per year.
  • Based on estimates for the next years, ASLE will show a very strong growth in Revenue. The Revenue will grow by 21.36% on average per year.
EPS Next Y86.51%
EPS Next 2Y65.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year19.09%
Revenue Next 2Y21.36%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
ASLE Yearly Revenue VS EstimatesASLE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
ASLE Yearly EPS VS EstimatesASLE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. ASLE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.60 indicates a rather expensive valuation of ASLE.
  • Compared to the rest of the industry, the Price/Earnings ratio of ASLE indicates a rather cheap valuation: ASLE is cheaper than 91.03% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ASLE to the average of the S&P500 Index (25.23), we can say ASLE is valued slightly cheaper.
  • Based on the Price/Forward Earnings ratio of 9.44, the valuation of ASLE can be described as reasonable.
  • 97.44% of the companies in the same industry are more expensive than ASLE, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.28, ASLE is valued rather cheaply.
Industry RankSector Rank
PE 17.6
Fwd PE 9.44
ASLE Price Earnings VS Forward Price EarningsASLE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ASLE is valued cheaper than 88.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.64
ASLE Per share dataASLE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • ASLE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ASLE's earnings are expected to grow with 65.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y65.07%
EPS Next 3YN/A

0

5. ASLE Dividend Analysis

5.1 Amount

  • ASLE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ASLE Fundamentals: All Metrics, Ratios and Statistics

AERSALE CORP

NASDAQ:ASLE (3/20/2026, 8:00:01 PM)

After market: 6.16 0 (0%)

6.16

-0.12 (-1.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)03-05
Earnings (Next)05-05
Inst Owners59.06%
Inst Owner Change1.94%
Ins Owners2.77%
Ins Owner Change-0.1%
Market Cap290.69M
Revenue(TTM)N/A
Net Income(TTM)5.88M
Analysts45.71
Price Target8.16 (32.47%)
Short Float %2.79%
Short Ratio4.09
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)239.17%
Min EPS beat(2)-75.26%
Max EPS beat(2)553.6%
EPS beat(4)1
Avg EPS beat(4)79.68%
Min EPS beat(4)-157.67%
Max EPS beat(4)553.6%
EPS beat(8)2
Avg EPS beat(8)24.08%
EPS beat(12)3
Avg EPS beat(12)-3.77%
EPS beat(16)6
Avg EPS beat(16)24.15%
Revenue beat(2)1
Avg Revenue beat(2)-1.85%
Min Revenue beat(2)-25.64%
Max Revenue beat(2)21.94%
Revenue beat(4)2
Avg Revenue beat(4)-7.61%
Min Revenue beat(4)-27.97%
Max Revenue beat(4)21.94%
Revenue beat(8)3
Avg Revenue beat(8)-11.66%
Revenue beat(12)3
Avg Revenue beat(12)-14.22%
Revenue beat(16)6
Avg Revenue beat(16)-7.75%
PT rev (1m)0%
PT rev (3m)14.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-26.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 17.6
Fwd PE 9.44
P/S 0.86
P/FCF N/A
P/OCF 90.7
P/B 0.7
P/tB 0.77
EV/EBITDA 12.64
EPS(TTM)0.35
EY5.68%
EPS(NY)0.65
Fwd EY10.6%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.07
OCFY1.1%
SpS7.19
BVpS8.84
TBVpS8.02
PEG (NY)0.2
PEG (5Y)N/A
Graham Number8.34
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 1.41%
ROCE 2.39%
ROIC 1.78%
ROICexc 1.8%
ROICexgc 1.93%
OM 4.03%
PM (TTM) 1.73%
GM 30.83%
FCFM N/A
ROA(3y)2.74%
ROA(5y)3.56%
ROE(3y)3.3%
ROE(5y)4.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-51.13%
ROICexgc growth 5YN/A
ROICexc growth 3Y-49.58%
ROICexc growth 5YN/A
OM growth 3Y-38.78%
OM growth 5YN/A
PM growth 3Y-45.72%
PM growth 5YN/A
GM growth 3Y-4.95%
GM growth 5YN/A
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA 3.8
Cap/Depr 50.56%
Cap/Sales 2.88%
Interest Coverage 1.89
Cash Conversion 9.71%
Profit Quality N/A
Current Ratio 4.41
Quick Ratio 0.92
Altman-Z 2.14
F-Score5
WACC10.48%
ROIC/WACC0.17
Cap/Depr(3y)91.07%
Cap/Depr(5y)58.73%
Cap/Sales(3y)3.18%
Cap/Sales(5y)2.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.21%
EPS 3Y-33.12%
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y86.51%
EPS Next 2Y65.07%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.02%
Revenue Next Year19.09%
Revenue Next 2Y21.36%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y264.14%
EBIT growth 3Y-38.5%
EBIT growth 5YN/A
EBIT Next Year350%
EBIT Next 3Y89.92%
EBIT Next 5YN/A
FCF growth 1Y96.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y101.93%
OCF growth 3Y-47.9%
OCF growth 5YN/A

AERSALE CORP / ASLE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AERSALE CORP (ASLE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ASLE.


What is the valuation status for ASLE stock?

ChartMill assigns a valuation rating of 6 / 10 to AERSALE CORP (ASLE). This can be considered as Fairly Valued.


Can you provide the profitability details for AERSALE CORP?

AERSALE CORP (ASLE) has a profitability rating of 3 / 10.


What is the financial health of AERSALE CORP (ASLE) stock?

The financial health rating of AERSALE CORP (ASLE) is 3 / 10.


Can you provide the expected EPS growth for ASLE stock?

The Earnings per Share (EPS) of AERSALE CORP (ASLE) is expected to grow by 86.51% in the next year.